- PR Newswire•3 days ago
VANCOUVER, April 27, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that David Dean, VP Business Development and Investor Relations of Cardiome, will provide an update on the company's progress at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference at the Sheraton Centre Toronto Hotel in Toronto, on Monday May 1, 2017 at 3:30 p.m. EDT.
- CNW Group•3 days ago
Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference
- Accesswire•4 days ago
Research Reports Initiated on Healthcare Stocks: Cardiome Pharma, Immunovaccine, Oncolytics Biotech, and Aeterna Zentaris
LONDON, UK / ACCESSWIRE / April 26, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...
COM.TO : Summary for CARDIOME PHARMA CORP - Yahoo Finance
Cardiome Pharma Corp. (COM.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||4.48 - 4.74|
|52 Week Range||3.25 - 8.15|
|PE Ratio (TTM)||-5.85|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|